Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-057561

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 5, 2018M600$50.51A31,971D
Common StockNov 5, 2018M700$75.60A32,671D
Common StockF2Nov 5, 2018S600$136.49D32,071D
Common StockF3Nov 5, 2018S948$137.6985D31,123D
Common StockF4Nov 5, 2018S252$138.2735D30,871D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F5$50.51Nov 5, 2018M600D—Mar 1, 2026Common Stock60014,600D
Stock Option (right to buy)F6$75.60Nov 5, 2018M700D—Feb 1, 2027Common Stock70031,300D

Explanation of responses